Search Results for: human embryo genetic modification

Juan Carlos Izpisua Belmonte Cell Paper on Gene Editing for Mitochondrial Disease

Figure-6B

The Juan Carlos Izpisua Belmonte group published a Cell paper today on using gene editing to reverse mutations associated with human mitochondrial disease. The paper is Reddy, et al. and is entitled, “Selective Elimination of Mitochondrial Mutations in the Germline by Genome Editing”. The authors report success using TALEN-based gene editing or mitochondrial-direct restriction enzyme (mito-ApaLI) …

Juan Carlos Izpisua Belmonte Cell Paper on Gene Editing for Mitochondrial Disease Read More »

ABCD Plan

Practical Plan for Managing Human Germline Genetic Modification CRISPR-Cas9 gene editing technology is a game changer on many levels both inside and soon outside the lab. There is a growing sense of urgency amongst biomedical scientists to take a proactive approach to current and future use of CRISPR technology in human germ cells and embryos. …

ABCD Plan Read More »

UK OKs 3-Person IVF: Perspectives

3-person-IVF2

With the House of Lords vote yesterday, the UK officially became the only country in the world to have legalized human genetic modification via 3-Person IVF. The point of this “mitochondrial transfer” or “3-person IVF” technology is not directly to genetically modify humans specifically, but it still will lead to that result in any case. …

UK OKs 3-Person IVF: Perspectives Read More »

Myths about 3-person IVF mitochondrial transfer

3-person-IVF2

It’s been somewhat of a helter-skelter time for the new technology often referred to as 3-person IVF or mitochondrial transfer as the UK considers whether to legalize this experimental technology for use in humans. I believe that this technology is not ready now for use in humans and for more background on why as well …

Myths about 3-person IVF mitochondrial transfer Read More »

Austen Heinz of Cambrian Genomics Interview: GMO creatures & people

Austen-Heinz

What’s Cambrian Genomics? With rapid advances in genomics, gene editing, and methods to reproduce life in the lab such as cloning, today creating genetically modified organisms (GMOs) has never been easier. While there have been of course loads of discussions of GMOs in the past, we are entering a new era of what one might …

Austen Heinz of Cambrian Genomics Interview: GMO creatures & people Read More »

Response from Drs. Braude & Lovell-Badge to My Letter on Mitochondrial Transfer/3-Parent Technology

3-parent-baby

The following is a response to my Open Letter to the UK Parliament on mitochondrial transfer/3-parent technology from Drs. Peter Braude and Robin Lovell-Badge. Dear Professor Knoepfler, We read your open letter to the UK Parliament and the Science and Technology Committee with interest and concern. We are two scientists, like you, with particular interests …

Response from Drs. Braude & Lovell-Badge to My Letter on Mitochondrial Transfer/3-Parent Technology Read More »

Why the FDA should not green-light 3-parent reproduction

3-parent-baby

An FDA committee began a meeting yesterday that continues today to consider permitting new assisted reproduction-based “3-parent” technology that could address mitochondrial disorders, a serious human health problem. The technology also raises complex health issues of its own and invokes ethical questions. The goal of the FDA meeting is articulated this way: “the committee will …

Why the FDA should not green-light 3-parent reproduction Read More »

Jeanne Loring interview: optimism on clinical translation of IPS cells

Loring-in-lab-1

One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You …

Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »

Interview with Gary Rabin of Advanced Cell Technology (ACT)

Gary-Rabin-headshot-formatted-5.25

One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …

Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »